Table 1:
SM− n=764 |
SM+ n=177 |
|
---|---|---|
Age: median (IQR)a | 30 (23 – 40) | 30 (23 – 36) |
Sex: n (%)a | ||
Female | 472 (61.8%) | 95 (53.7%) |
Male | 292 (38.2%) | 82 (46.3%) |
Race: n (%) | ||
Black African | 764 (100%) | 177 (100%) |
Recruitment Site: n (%)a | ||
Kisumu City (urban) | 426 (59%) | 103 (60%) |
Kombewa (rural) | 296 (41%) | 68 (40%) |
Hemoglobin g/dL: median (IQR)a | 12.7 (11.4 – 13.9) | 13·0 (11.7 – 14.1) |
Pregnant: n (%)a | 1 (0.23%) | 0 (0%) |
Malaria: n (%)a | 2 (0.37%) | 0 (0%) |
Any Helminth (not including SM): n (%)a | 77 (10.1%) | 19 (10.7%) |
Ascarisa | 13 (1.7%) | 1 (0.6%) |
Trichurisa | 16 (2.1%) | 5 (2.8%) |
Hookworma | 52 (6.8%) | 14 (7.9%) |
Helminth Species (not including SM): n (%)a | ||
0 | 687 (89.9%) | 158 (89.3%) |
1 | 73 (9.6%) | 18 (10.2%) |
2 | 4 (0.52%) | 1 (0.56%) |
SM Features | ||
epg: median (IQR) | NA | 48 (24 – 144) |
Light Intensity (1–99 epg): n (%) | NA | 122 (68.9%) |
Moderate Intensity (100–399 epg): n (%) | NA | 41 (23.2%) |
Heavy Intensity (400+ epg): n (%) | NA | 14 (7.9%) |
HIV Features | ||
Positive: n (%)a | 301 (39.4%) | 67 (37.9%) |
Among Positive | ||
Viral Load: median (IQR)a | 30058 (1775 – 150 826) | 18879 (2442 – 101 875) |
Suppressed Viral Load: n (%) | 25 (8.3%) | 5 (7.5%) |
CD4 Count (cells/μL): median (IQR) | 395 (184 – 600) | 467 (299 – 646) |
On ART: n (%) | ||
Yes | 50 (16.6%) | 6 (9.0%) |
No | 203 (67.5%) | 55 (82.0%) |
Unknown | 48 (15.9%) | 6 (9.0%) |
Tuberculosis Features | ||
QFT IFNγIU/mL (TB Antigen-Nil): median (IQR) | ||
HC | 0.00 (0.00 – 0.05) | 0.00 (0.00 – 0.04) |
LTBI | 7.00 (2.12 – 9.57) | 7.07 (1.76 – 9.53) |
Abnormal Chest x-ray: n (%) | ||
HC | 3 (1.3%) | 0 (0%) |
LTBI | 8 (2.5%) | 2 (2.7%) |
: Included in propensity score and outcome regression models.
Abbreviations: IQR, Interquartile Range; epg, Eggs Per Gram; QFT, QuantiFERON-TB Gold.